The resolutions arrived at attest to the NIS’s commitment to evolving with the times, not merely to react to threats but to anticipate them. Central to the conference outcomes was the agency’s ...
1 The data in this document are based on the company's non-GAAP figures, which include the proportionate consolidation of jointly controlled businesses and do not include share-based payment ...
Winter is approaching, and with it come stylish wool hats that replace the traditional headscarf with elegance and comfort. Meet "Lerosha," a brand of unique, hand-designed wool hats created by Noy ...
The resolutions arrived at attest to the NIS’s commitment to evolving with the times, not merely to react to threats but to anticipate them. Central to the conference outcomes was the agency’s ...
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments.
If the Austrian’s outlook on life and champion’s drive are any indication, there’s every reason to be believe his impact will be felt for generations to come.
In rare diseases, rare mutations have long been thought of as the only contributor. Genetic analyses of people with such conditions now suggest that the effects of common genetic variants can ...